Skip to main content
. Author manuscript; available in PMC: 2021 Jul 21.
Published in final edited form as: Breast Cancer Res Treat. 2020 Sep 13;185(1):1–12. doi: 10.1007/s10549-020-05917-7

Fig. 1.

Fig. 1

Inclusion criteria and assignment of analysis for each group. ADC apparent diffusion coefficient, DCE dynamic contrast-enhanced imaging, DWI diffusion-weighted imaging, NAST neoadjuvant systemic therapy, NV necrosis-only volume, PE percent enhancement, T2WI T2-weighted imaging, TNBC triple-negative breast cancer, TTV total tumor volume including necrosis, TV tumor volume without necrosis